Evolutionary Genomics SEC Filings

Type
Report
Date
15-12G15-12G-Formular4/28/2023
10-KJahresbericht3/9/2023
10-QQuartalsbericht10/21/2022
10-QQuartalsbericht8/8/2022
4Insidertransaktion5/25/2022
4Insidertransaktion5/25/2022
4Insidertransaktion5/25/2022
10-QQuartalsbericht5/16/2022
DD-Formular5/12/2022
4Insidertransaktion3/31/2022
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben3/31/2022
10-KJahresbericht3/22/2022
10-QQuartalsbericht11/1/2021
10-QQuartalsbericht8/6/2021
4Insidertransaktion5/21/2021
10-QQuartalsbericht5/13/2021
10-KJahresbericht3/31/2021
4Insidertransaktion1/4/2021
10-QQuartalsbericht11/13/2020
10-QQuartalsbericht8/19/2020
NT 10-QNT 10-Q-Formular8/14/2020
10-QQuartalsbericht5/12/2020
10-K/A10-K/A-Formular4/24/2020
10-KJahresbericht3/30/2020
4Insidertransaktion10/29/2019
4Insidertransaktion10/29/2019
4Insidertransaktion10/29/2019
10-QQuartalsbericht10/17/2019
10-QQuartalsbericht8/12/2019
DD-Formular5/15/2019
10-QQuartalsbericht5/15/2019
10-KJahresbericht4/1/2019
10-QQuartalsbericht11/14/2018
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben10/4/2018
10-QQuartalsbericht7/27/2018
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben5/21/2018
10-QQuartalsbericht5/15/2018
10-KJahresbericht3/5/2018
10-QQuartalsbericht11/13/2017
10-QQuartalsbericht8/3/2017
10-QQuartalsbericht5/11/2017
10-KJahresbericht2/10/2017
10-QQuartalsbericht11/4/2016
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben9/9/2016
10-QQuartalsbericht8/12/2016
10-QQuartalsbericht5/11/2016
DD-Formular3/11/2016
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben2/25/2016
10-K/A10-K/A-Formular2/25/2016
10-KJahresbericht2/19/2016
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben10/23/2015
10-QQuartalsbericht10/6/2015
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben9/30/2015
424B3424B3-Formular9/11/2015
EFFECTEFFECT-Formular9/11/2015
CORRESPCORRESP-Formular9/9/2015
S-4/AS-4/A-Formular8/28/2015
10-QQuartalsbericht8/4/2015
S-4/AS-4/A-Formular7/30/2015
UPLOADUPLOAD-Formular7/21/2015
CORRESPCORRESP-Formular7/6/2015
S-4/AS-4/A-Formular7/2/2015
10-QQuartalsbericht5/14/2015
UPLOADUPLOAD-Formular5/1/2015
S-4S-4-Formular4/2/2015
10-KJahresbericht3/5/2015
10-QQuartalsbericht11/14/2014
SC 14F1SC 14F1-Formular10/17/2014
SC 13D/ASC 13D/A-Formular10/8/2014
4Insidertransaktion10/8/2014
4Insidertransaktion10/8/2014
8-K/A8-K/A-Formular10/8/2014
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben10/7/2014
4Insidertransaktion10/3/2014
10-QQuartalsbericht8/19/2014
NT 10-QNT 10-Q-Formular8/14/2014
SC 13DSC 13D-Formular6/16/2014
33-Formular6/16/2014
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben6/12/2014
10-QQuartalsbericht5/12/2014
10-KJahresbericht4/16/2014
NT 10-KNT 10-K-Formular3/25/2014
10-QQuartalsbericht11/13/2013
10-QQuartalsbericht8/19/2013
NT 10-QNT 10-Q-Formular8/14/2013
UPLOADUPLOAD-Formular8/2/2013
10-QQuartalsbericht5/20/2013
NT 10-QNT 10-Q-Formular5/15/2013
10-KJahresbericht4/15/2013
10-Q/A10-Q/A-Formular4/9/2013
10-Q/A10-Q/A-Formular4/9/2013
10-Q/A10-Q/A-Formular4/9/2013
NT 10-KNT 10-K-Formular3/22/2013
10-K/A10-K/A-Formular2/19/2013
CORRESPCORRESP-Formular2/19/2013
UPLOADUPLOAD-Formular11/13/2012
10-QQuartalsbericht11/13/2012
CORRESPCORRESP-Formular11/5/2012
UPLOADUPLOAD-Formular9/14/2012
10-QQuartalsbericht8/14/2012

Evolutionary Genomics Documents 2026

This page contains all official documents and SEC filings for Evolutionary Genomics stock (FNAM, ISIN: US30051F1012). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 100 documents are available. Data is updated regularly to provide investors with a complete overview of Evolutionary Genomics's regulatory filings.

Evolutionary Genomics Stock analysis

Evolutionary Genomics Evolutionary Genomics, Inc. generates revenue through the identification and validation of genes impacting commercially valuable traits in crops for the agriculture industry. The company utilizes its Adapted Traits Platform (ATP) to identify genes that control important traits in plants and animals, focusing on yield increases in corn and rice, drought tolerance, sugar content in tomatoes, and pest/disease resistance in soybeans, cassava, beans, tomatoes, and cotton. The firm applies ATP in research projects for agricultural clients seeking improved crop performance. The company targets agricultural industry clients who require gene-based solutions for enhancing crop traits such as yield, drought tolerance, and pest resistance. The Adapted Traits Platform (ATP) is central to the company's product offering, enabling throughput molecular evolution analysis through non-synonymous site (Ka) and synonymous site (Ks) analysis to identify positively selected genes. This platform identifies genes that have successfully adapted to impart new or improved traits in agricultural crops. The firm's research projects include specific applications like yield increases in corn and rice, drought tolerance in crops, and pest resistance in soybeans, cassava, beans, tomatoes, and cotton. Agricultural companies and research institutions are the primary buyers of these gene identification services. Evolutionary Genomics, Inc. focuses on the agriculture industry, specifically targeting clients who need gene validation for crop improvement. The company's services are used to identify genes responsible for commercially valuable traits such as yield, drought tolerance, and pest resistance. The firm's ATP platform is applied in research projects for crops including corn, rice, soybeans, cassava, beans, tomatoes, and cotton. Agricultural clients seeking to enhance their crop traits through gene-based solutions are the key market segment for the company's offerings.